Moreover, diverse approaches, including JAK2 inhibition, STAT1 antisense oligonucleotides, and STAT3 gene knockdown, have been proven to counteract the harmful effects of JAK/STAT activation in cultured renal cells [17,19–21] and in the development of diabetes in vivo [18,21]. Here, SOAT1 is linked to diabetes mellitus.